Dr. Heath is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Karmanos Cancer Center
4100 John R Hwcrc 4th Fl
Detroit, MI 48201Phone+1 313-576-8624Fax+1 313-576-8767
Education & Training
- Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 1996 - 1999
- MedStar Health/Georgetown University HospitalResidency, Internal Medicine, 1993 - 1996
- Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1993
Certifications & Licensure
- MI State Medical License 2003 - 2025
- MN State Medical License 2024 - 2025
- MD State Medical License 1996 - 2004
- VA State Medical License 1994 - 2004
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
Clinical Trials
- 17-AAG in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Previous Hormone Therapy Start of enrollment: 2005 Jan 01
- Diindolylmethane in Treating Patients With Nonmetastatic Prostate Cancer That Has Not Responded To Previous Hormone Therapy Start of enrollment: 2005 Aug 01
- Eribulin Mesylate in Treating Patients With Locally Advanced or Metastatic Cancer of the Urothelium and Kidney Dysfunction Start of enrollment: 2006 Oct 23
- Join now to see all
Publications & Presentations
PubMed
- 777 citationsGenomic correlates of clinical outcome in advanced prostate cancer.Wassim Abida, Joanna Cyrta, Glenn Heller, Davide Prandi, Joshua Armenia
Proceedings of the National Academy of Sciences of the United States of America. 2019-06-04 - 807 citationsIntegrative clinical genomics of advanced prostate cancer.Dan Robinson, Eliezer M Van Allen, Yi-Mi Wu, Nikolaus Schultz, Robert J Lonigro
Cell. 2015-05-21 - 105 citationsCabazitaxel plus carboplatin for the treatment of men with metastatic castration-resistant prostate cancers: a randomised, open-label, phase 1-2 trial.Paul G. Corn, Elisabeth I. Heath, Amado J. Zurita, Naveen Ramesh, Lianchun Xiao
The Lancet. Oncology. 2019-10-01
Journal Articles
- Willingness to Discuss Clinical Trials Among Black vs White Men with Prostate CancerElisabeth Heath, MD, JAMA Oncology
Press Mentions
- Local Doctors Weigh in on AI in MedicineOctober 8th, 2024
- Intervention to Improve Patient-Physician Communication May Improve Black Patient Participation in Clinical Trials, Study Led by Karmanos ResearcherFebruary 27th, 2023
- Karmanos Receives Renewal of Membership in Prestigious Prostate Cancer Clinical Trials ConsortiumOctober 24th, 2022
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: